D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$728M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$625M |
| 3 |
Merck
MRK
|
+$498M |
| 4 |
Bank of America
BAC
|
+$487M |
| 5 |
Fortinet
FTNT
|
+$321M |
Top Sells
| 1 |
Tesla
TSLA
|
+$696M |
| 2 |
Adobe
ADBE
|
+$610M |
| 3 |
Accenture
ACN
|
+$518M |
| 4 |
Microsoft
MSFT
|
+$495M |
| 5 |
Broadcom
AVGO
|
+$471M |
Sector Composition
| 1 | Technology | 22.95% |
| 2 | Consumer Discretionary | 14.11% |
| 3 | Healthcare | 10.4% |
| 4 | Financials | 9.83% |
| 5 | Industrials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Koppers
KOP
$543M
| $335K | ﹤0.01% |
9,173
+1,714
| +23% | +$62.6K |
|
2502
iShares MSCI Brazil Small-Cap ETF
EWZS
$181M
| $333K | ﹤0.01% |
26,467
-68,293
| -72% | -$859K |
|
|
AUTL
2503
Autolus Therapeutics
AUTL
$367M
| $333K | ﹤0.01% |
91,687
-491,178
| -84% | -$1.78M |
|
2504
Melco Resorts & Entertainment
MLCO
$3.8B
| $331K | ﹤0.01% |
+42,548
| New | +$331K |
|
2505
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.14B
| $331K | ﹤0.01% |
4,181
-1,800
| -30% | -$142K |
|
2506
iShares MSCI Poland ETF
EPOL
$447M
| $331K | ﹤0.01% |
+13,644
| New | +$331K |
|
2507
PLAYSTUDIOS Inc
MYPS
$120M
| $329K | ﹤0.01% |
217,593
-4,376
| -2% | -$6.61K |
|
2508
Cambria Shareholder Yield ETF
SYLD
$933M
| $326K | ﹤0.01% |
4,498
-385
| -8% | -$27.9K |
|
2509
Standex International
SXI
$2.44B
| $325K | ﹤0.01% |
1,780
| – | – |
|
2510
Autohome
ATHM
$3.4B
| $324K | ﹤0.01% |
9,943
+1,184
| +14% | +$38.6K |
|
2511
Hingham Institution for Saving
HIFS
$599M
| $322K | ﹤0.01% |
1,324
+105
| +9% | +$25.5K |
|
2512
Jack Henry & Associates
JKHY
$11.6B
| $321K | ﹤0.01% |
1,820
-1,400
| -43% | -$247K |
|
|
UHT
2513
Universal Health Realty Income Trust
UHT
$569M
| $321K | ﹤0.01% |
7,016
-7,943
| -53% | -$363K |
|
2514
Clearway Energy Class C
CWEN
$3.35B
| $321K | ﹤0.01% |
10,448
-71,641
| -87% | -$2.2M |
|
2515
Booz Allen Hamilton
BAH
$12.6B
| $319K | ﹤0.01% |
1,962
-39,702
| -95% | -$6.46M |
|
2516
Valaris
VAL
$3.75B
| $319K | ﹤0.01% |
+5,717
| New | +$319K |
|
2517
Inotiv
NOTV
$47.8M
| $318K | ﹤0.01% |
187,079
+39,200
| +27% | +$66.6K |
|
2518
Open Lending Corp
LPRO
$253M
| $317K | ﹤0.01% |
51,762
-28,039
| -35% | -$172K |
|
2519
Applied Therapeutics
APLT
$64M
| $316K | ﹤0.01% |
+37,235
| New | +$316K |
|
|
CGC
2520
Canopy Growth
CGC
$434M
| $315K | ﹤0.01% |
65,407
+50,930
| +352% | +$245K |
|
|
MRNS
2521
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $315K | ﹤0.01% |
+178,801
| New | +$315K |
|
2522
Cato Corp
CATO
$89.6M
| $315K | ﹤0.01% |
63,061
+24,001
| +61% | +$120K |
|
2523
Corpay
CPAY
$21.5B
| $315K | ﹤0.01% |
1,006
-2,095
| -68% | -$655K |
|
2524
iShares US Healthcare ETF
IYH
$2.74B
| $314K | ﹤0.01% |
4,831
-1,129
| -19% | -$73.4K |
|
2525
iShares MSCI USA Equal Weighted ETF
EUSA
$1.56B
| $313K | ﹤0.01% |
+3,274
| New | +$313K |
|